Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Journal of Gastroenterology|December 9, 2024
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinomaRyoichi Miura, Atsushi Ono, Hikaru Nakahara, et al.
The Journal of Infection|October 31, 2015
Effect of tenofovir disoproxil fumarate on drug-resistant HBV clonesEisuke Murakami, Masataka Tsuge, Nobuhiko Hiraga, et al.
Microorganisms|May 4, 2026
A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut MicrobiotaYusuke Tanaka, Daiki Miki, C Nelson Hayes, et al.
Cancers|April 13, 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular CarcinomaYuki Shirane, Yasutoshi Fujii, Atsushi Ono, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2020
Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumabTomokazu Kawaoka, Yuwa Ando, Masami Yamauchi, et al.
Journal of Viral Hepatitis|November 16, 2020
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection-Pilot studyYuji Teraoka, Michio Imamura, Takuro Uchida, et al.
Scientific Reports|September 2, 2017
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMSTsunehiro Ochi, Takumi Kawaguchi, Takashi Nakahara, et al.
Clinical Journal of Gastroenterology|July 17, 2015
Multicentric hepatocarcinogenesis at 6 and 13 years after sustained viral response to hepatitis C virusYoshimasa Hashimoto, Daisuke Miyaki, Eisuke Murakami, et al.
The Journal of Infectious Diseases|June 10, 2020
Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1Yasue Takeuchi, Masataka Tsuge, Ken Tsushima, et al.
Clinical Journal of Gastroenterology|November 17, 2020
A case with life-threatening secondary sclerosing cholangitis caused by nivolumabYuki Yoshikawa, Michio Imamura, Kenji Yamaoka, et al.
Pageof 20